Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Investigate Something else for Less: Financial plan Travel Objections - 210 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- 3David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- 419 Peculiar Films You Shouldn't Watch With Your Mum
- 5Sustaining Public activity and Connections: Key Methodologies
- Vote in favor of Your #1 BWM Vehicles
- 7 Methods for further developing Rest Quality
- The Ascent of the Kona SUV: How Hyundai's Reduced Hybrid Is Vanquishing the Streets
- 'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- Instructions to Decide the Best SUV Size for Seniors
- More parents refusing vitamin K shots for newborns, study finds
- When will the Epstein files be released — and will they reveal anything new?
- How Trump's marijuana executive order could change medical research landscape
- Remote Work Survival manual: Helping Efficiency at Home
